跳至主要内容
临床试验/NCT03795662
NCT03795662招募中不适用

Surviving Pneumonia

Nordsjaellands Hospital1 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2019年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,500
试验地点
1
主要终点
Number of death from any causes

研究概览

简要总结

The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Infiltrate on chest radiograph plus one or more of the following:
  • Fever (temperature, ≥38.0°C)
  • Hypothermia (<35.0°C),
  • New cough with or without sputum production
  • Pleuritic chest pain
  • Altered breath sounds on auscultation.

排除标准

  • Patients unable to give informed consent
  • Patients unwilling to give informed consent

结局指标

主要结局

Number of death from any causes

时间窗: From date of admission until the day of death from any causes, up to 24 months

Assessed through patient files

Number of participants who develop diabetes

时间窗: Up to 24 months

Assessed through patient files and the national registers

次要结局

  • Oral glucose tolerance test(Day 1, discharge (an average of 5 days), 1 month and 6-month)
  • Number of participants who are readmitted(Up to 6 months)
  • Length of hospital stay(Participants will be followed for the duration of hospital stay, an expected average of 5 days)

研究者

发起方
Nordsjaellands Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Birgitte Lindegaard Madsen

Associated professor, MD, PhD

Nordsjaellands Hospital

研究点 (1)

Loading locations...

相似试验